Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuji Sumitomo

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 11, 2010
CD4+CD25-LAG-3+ T cells in mouse and humanShuji Sumitomo, Kazuhiko Yamamoto
International Journal of Rheumatic Diseases|April 19, 2025
Case Report: Successful Remission With Upadacitinib in Behçet's Syndrome Following a History of PFAPA SyndromeHideki Oka, Shuji Sumitomo, Daisuke Yamashita, et al.
Annals of the Rheumatic Diseases|December 21, 2012
Regulatory cell subsets in the control of autoantibody production related to systemic autoimmunityKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The functions of CD4+CD25-LAG3+ regulatory T cells and Egr2 in the regulation of autoimmunity]Keishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Frontiers in Immunology|May 9, 2012
Regulatory T cell-mediated control of autoantibody-induced inflammationKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
International Immunology|December 10, 2015
Therapeutic potential of regulatory cytokines that target B cellsKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Frontiers in Immunology|March 2, 2026
Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseasesHideki Oka, Shuji Sumitomo, Chisato Miyakoshi, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Rhabdomyolysis Induced by Isoniazid in a Patient with Rheumatoid Arthritis and End-stage Renal Disease: A Case Report and Review of the LiteratureToshihiko Komai, Shuji Sumitomo, Shuzo Teruya, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Roles of LAG3 and EGR2 in regulatory T cellsTomohisa Okamura, Keishi Fujio, Shuji Sumitomo, et al.
JAK-STAT|September 24, 2013
Egr2 and Egr3 are the unique regulators for systemic autoimmunityShuji Sumitomo, Keishi Fujio, Tomohisa Okamura, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 11, 2010
CD4+CD25-LAG-3+ T cells in mouse and humanShuji Sumitomo, Kazuhiko Yamamoto
International Journal of Rheumatic Diseases|April 19, 2025
Case Report: Successful Remission With Upadacitinib in Behçet's Syndrome Following a History of PFAPA SyndromeHideki Oka, Shuji Sumitomo, Daisuke Yamashita, et al.
Annals of the Rheumatic Diseases|December 21, 2012
Regulatory cell subsets in the control of autoantibody production related to systemic autoimmunityKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The functions of CD4+CD25-LAG3+ regulatory T cells and Egr2 in the regulation of autoimmunity]Keishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Frontiers in Immunology|May 9, 2012
Regulatory T cell-mediated control of autoantibody-induced inflammationKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
International Immunology|December 10, 2015
Therapeutic potential of regulatory cytokines that target B cellsKeishi Fujio, Tomohisa Okamura, Shuji Sumitomo, et al.
Frontiers in Immunology|March 2, 2026
Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseasesHideki Oka, Shuji Sumitomo, Chisato Miyakoshi, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Rhabdomyolysis Induced by Isoniazid in a Patient with Rheumatoid Arthritis and End-stage Renal Disease: A Case Report and Review of the LiteratureToshihiko Komai, Shuji Sumitomo, Shuzo Teruya, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Roles of LAG3 and EGR2 in regulatory T cellsTomohisa Okamura, Keishi Fujio, Shuji Sumitomo, et al.
JAK-STAT|September 24, 2013
Egr2 and Egr3 are the unique regulators for systemic autoimmunityShuji Sumitomo, Keishi Fujio, Tomohisa Okamura, et al.
Pageof 7